Completed PHASE4 INTERVENTIONAL 2-arm NCT02469740

Peripheral Endothelial Function Assessment of Patients on Ticagrelor vs. Clopidogrel Who Have Undergone PCI

Peripheral Endothelial Function Assessment of Patients on Ticagrelor vs. Clopidogrel Who Have Undergone Percutaneous Coronary Intervention - a Randomised, Crossover Study.

Sponsor: University Hospital of Limerick

Conditions Coronary Artery Disease Endothelial Dysfunction Myocardial Ischemia

Interventions Clopidogrel Ticagrelor

Updated 5 times since 2017 Last updated: Mar 10, 2016 Started: Jul 31, 2015 Primary completion: Jan 31, 2016 Completion: Jan 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02469740, this PHASE4 trial focuses on Coronary Artery Disease and Endothelial Dysfunction and remains completed. Sponsored by University Hospital of Limerick, it has been updated 5 times since 2015, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jul 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital of Limerick

Data source: University Hospital of Limerick

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dooradoyle, Ireland